Abstract
Aim:
To investigate the analgesic effect of cobratoxin (CTX), a long-chain α-neurotoxin from Thailand cobra venom, in a rat model of formalin-induced inflammatory pain.
Methods:
Inflammatory pain was induced in SD rats via injecting 5% formalin (50 μL) into the plantar surface of their right hind paw. CTX and other agents were ip administered before formalin injection. The time that the animals spent for licking the injected paw was counted every 5 min for 1 h.
Results:
CTX (25, 34, and 45 μg/kg) exhibited a dose-dependent analgesic effect during the phase 1 (0–15 min) and phase 2 (20–60 min) response induced by formalin. Pretreatment with naloxone (0.5 or 2.5 mg/kg) did not block the analgesic effect of CTX. Pretreatment with atropine at 5 mg/kg, but not at 2.5 mg/kg, antagonized the analgesic effect of CTX. Treatment with the nonselective nAChR antagonist mecamylamine (3 mg/kg) inhibited the analgesic effects of CTX in Phase 1 and Phase 2 responses, while with the selective α7-nAChR antagonist methyllycaconitine (3 mg/kg) antagonized the effect of CTX only in the Phase 1 response. Treatment with the α7-nAChR agonist PNU282987 (3 mg/kg) significantly reduced the formalin-induced phase 2 pain response, but only slightly reduced the Phase 1 pain response.
Conclusion:
The results suggest that CTX exerts an antinociceptive effect in formalin-induced inflammatory pain, which appears to be mediated by mAChR and α7-nAChR.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Nunes FP, Sampaio SC, Santoro ML, Sousa-e-Silva MC . Long-lasting anti-inflammatory properties of Crotalus durissus terrificus snake venom in mice. Toxicon 2007; 49: 1090–8.
Farsky SH, Antunes E, Mello SB . Pro and antiinflammatory properties of toxins from animal venoms. Curr drug targets inflamm Allergy 2005; 4: 401–11.
Yang CC . Cobrotoxin: structure and function. J Na Toxins 1999; 8: 221–33.
Grasset E . The cobra neurotoxin, pharmacology and clinical applications in the treatment of pain. Med Hyg (Geneve) 1952; 10: 55–8.
Servent D, Anti-Delbeke S, Gaillard C, Corringer PJ, Changeux JP, Menenz A . Molecular characterization of the specificity of interactions of various neurotoxins on two distinct nicotinic acetylcholine receptors. Eur J Pharmacol 2000; 393: 197–204.
Dajas-Bailador F, Costa G, Dajas F, Emmett. Effects of α-bungarotoxin, α-cobratoxin and fasciculin on the nicotine-evoked release of dopamine in the rat striatum in vivo. Neurochem Intl 1998; 33: 307–12.
Lena C, Changeux JP . Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 1997; 17: 576–85.
Chen ZX, Zhan HL, Gu ZL, Chen BW, Han R, Reid PF, et al. A long-form α-neurotoxin from cobra venom produces potent opioid independent analgesia1. Acta Pharmacol Sin 2006; 27: 402–8.
Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K . The formalin test: an evaluation of the method. Pain 1992; 51: 5–17.
Dubuisson D, Dennis SG . The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161–74.
Wheeler-Aceto H, Cowan A . Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 1991; 104: 35–44.
Ortiz MI, Castro-Olguın J, Pena-Samaniego N, Castaneda-Hernandez G . Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine. Pharmacol Biochem Behav 2005; 82: 695–703.
Castaneda-Hernandez G . Possible activation of ATP sensitive K+ channels by nalbuphine on the formalin test. Eur J Pain 2006; 10(supp1): S88.
Malmberg AB, Yaksh TL . Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136–46.
Ortiz MI, Granados-Soto V, Castaneda-Hernandez G . The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol Biochem Behav 2003; 76: 187–95.
Lozano-Cuenca J, Castaneda-Hernandez G, Granados-Soto V . Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib. Eur J Pharmacol 2005; 513: 81–91.
Dickenson AH, Sullivan AF . Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci Lett 1987; 83: 207–11.
Mccall WD, Tanner KD, Levine JD . Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 1996; 208: 45–8.
Pitcher GM, Henry JL . Second phase of formalin-induced excitation of spinal dorsal horn neurons in spinalized rats is reversed by sciatic nerve block. Eur J Neurosci 2002; 15: 1509–15.
Coderre TJ, Vaccarino AL, Melzack R . Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 1990; 535: 155–8.
Wang H . Modulation by nicotine on muscarinic receptor-effector systems. Acta Pharmacol Sin 1997; 18: 193–7.
Wang H, Cui WY, Liu CG . Regulatory effects of acutely repeated nicotine treatment towards central muscarinic receptors. Life Sci 1996; 59: 1415–21.
Wang H, Cui WY, Liu CH . Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist. Acta Pharmacol Sin 1996; 17: 497–9.
Yin X, Cui W, Hu G, Wang H . Desensitization of alpha7 nicotinic receptors potentiated the inhibitory effect on M-current induced by stimulation of muscarinic receptors in rat superior cervical ganglion neurons. J Neural Transm 2005; 112: 1133–48.
Dutertre S, Lewis RJ . Toxin insights into nicotinic acetylcholine receptors. Biochem Pharmacol 2006; 72: 661–70.
Wang Y, Su DM, Wang RH, Liu Y, Wang H . Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 2005; 132: 49–56.
Acknowledgements
This work was supported by Pre-research Funding of Soochow University (No Q3132821).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shi, Gn., Liu, Yl., Lin, Hm. et al. Involvement of cholinergic system in suppression of formalin-induced inflammatory pain by cobratoxin. Acta Pharmacol Sin 32, 1233–1238 (2011). https://doi.org/10.1038/aps.2011.65
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.65
Keywords
This article is cited by
-
Cobrotoxin could be an effective therapeutic for COVID-19
Acta Pharmacologica Sinica (2020)
